Difference between revisions of "HAEM4:High-Grade B-cell Lymphoma"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
(Created page with "{{Under Construction}} ==Primary Author(s)*== __TOC__ ==Graphical Data Links== Put your graphics here ==General Disease Overview / Description of Cancer Category== Put...")
 
 
Line 17: Line 17:
 
==WHO Classification Pages (Includes Links to Content)==
 
==WHO Classification Pages (Includes Links to Content)==
  
[[High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements]]
+
[[HAEM5:Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements]]
  
[[High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)]]
+
[[HAEM5:High-grade B-cell lymphoma, NOS]]
  
 
==Other Related Pages (Includes Links to Content)==
 
==Other Related Pages (Includes Links to Content)==

Latest revision as of 16:38, 4 December 2023

Primary Author(s)*

Graphical Data Links

Put your graphics here

General Disease Overview / Description of Cancer Category

Put your text here

WHO Classification Pages (Includes Links to Content)

HAEM5:Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements

HAEM5:High-grade B-cell lymphoma, NOS

Other Related Pages (Includes Links to Content)

Put your text here (use "Link" icon at top of page)

Additional Information

Put your text here

References

(use "Cite" icon at top of page)

EXAMPLE Book

  1. Arber DA, et al., (2017). Acute myeloid leukaemia with recurrent genetic abnormalities, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, and Siebert R, Editors. IARC Press: Lyon, France, p129-171.

Notes

*Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.

*The hierarchical tumour classification structure displayed on this page is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.